These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22335134)

  • 1. [S-adenosyl L-methionine in CNS diseases].
    Krzystanek M; Pałasz A; Krzystanek E; Krupka-Matuszczyk I; Wiaderkiewicz R; Skowronek R
    Psychiatr Pol; 2011; 45(6):923-31. PubMed ID: 22335134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of aggressive behavior and quality of life impairment following S-adenosyl-methionine (SAM-e) augmentation in schizophrenia.
    Strous RD; Ritsner MS; Adler S; Ratner Y; Maayan R; Kotler M; Lachman H; Weizman A
    Eur Neuropsychopharmacol; 2009 Jan; 19(1):14-22. PubMed ID: 18824331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of the dietary supplement S-adenosyl-L-methionine.
    Fetrow CW; Avila JR
    Ann Pharmacother; 2001 Nov; 35(11):1414-25. PubMed ID: 11724095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of behavioural symptoms and dementia in Parkinson's disease.
    Hanagasi HA; Emre M
    Fundam Clin Pharmacol; 2005 Apr; 19(2):133-46. PubMed ID: 15810893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic indications of S-adenosyl methionine in neuropsychiatry].
    Tramoni AV; Azorin JM
    Encephale; 1988; 14(3):113-8. PubMed ID: 2900133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-adenosylmethionine and depression.
    Nguyen M; Gregan A
    Aust Fam Physician; 2002 Apr; 31(4):339-43. PubMed ID: 12043126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modern pharmacotherapy in psychiatry].
    Vinar O
    Psychiatr Neurol Med Psychol Beih; 1966; 4-5():155-71. PubMed ID: 4157249
    [No Abstract]   [Full Text] [Related]  

  • 9. Silymarin and S-adenosyl-L-methionine (SAMe): two promising pharmacological agents in case of chronic alcoholic hepathopathy. A review and a point of view.
    Testino G; Leone S; Ansaldi F; Borro P
    Minerva Gastroenterol Dietol; 2013 Dec; 59(4):341-56. PubMed ID: 24212353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropharmacology of S-adenosyl methionine.
    Carney MW
    Clin Neuropharmacol; 1986; 9(3):235-43. PubMed ID: 2424592
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of behavioral abnormalities in patients with dementia].
    Wolf H; Gertz HJ
    MMW Fortschr Med; 2004 Jun; 146(24):43-5. PubMed ID: 15366492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of atypical antipsychotics in anxiety.
    Vulink NC; Figee M; Denys D
    Eur Neuropsychopharmacol; 2011 Jun; 21(6):429-49. PubMed ID: 21345655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of S-adenosyl-L-methionine in the treatment of alcoholic liver disease: introduction and summary of the symposium.
    Purohit V; Russo D
    Alcohol; 2002 Jul; 27(3):151-4. PubMed ID: 12163142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1991 May; 33(844):43-50. PubMed ID: 1674103
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for S-adenosyl-L-methionine (SAM-e) for the treatment of major depressive disorder.
    Papakostas GI
    J Clin Psychiatry; 2009; 70 Suppl 5():18-22. PubMed ID: 19909689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1989 Feb; 31(786):13-20. PubMed ID: 2563894
    [No Abstract]   [Full Text] [Related]  

  • 17. S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research.
    Sharma A; Gerbarg P; Bottiglieri T; Massoumi L; Carpenter LL; Lavretsky H; Muskin PR; Brown RP; Mischoulon D;
    J Clin Psychiatry; 2017 Jun; 78(6):e656-e667. PubMed ID: 28682528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New psychoactive drugs.
    Murray JB
    Genet Soc Gen Psychol Monogr; 1985 Nov; 111(4):429-53. PubMed ID: 2873081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychotropic effects of COX-2 inhibitors--a possible new approach for the treatment of psychiatric disorders.
    Müller N; Riedel M; Schwarz MJ
    Pharmacopsychiatry; 2004 Nov; 37(6):266-9. PubMed ID: 15551192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.